- Home
- FAMI vs CINGW Comparison
FAMI vs CINGW Comparison
Compare FAMI & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAMI
- CINGW
- Stock Information
- Founded
- FAMI 2015
- CINGW N/A
- Country
- FAMI China
- CINGW United States
- Employees
- FAMI N/A
- CINGW 13
- Industry
- FAMI Packaged Foods
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- FAMI Consumer Staples
- CINGW Health Care
- Exchange
- FAMI Nasdaq
- CINGW Nasdaq
- Market Cap
- FAMI 2.1M
- CINGW N/A
- IPO Year
- FAMI 2018
- CINGW 2021
- Fundamental
- Price
- FAMI $1.68
- CINGW $0.04
- Analyst Decision
- FAMI
- CINGW
- Analyst Count
- FAMI 0
- CINGW 0
- Target Price
- FAMI N/A
- CINGW N/A
- AVG Volume (30 Days)
- FAMI 28.7K
- CINGW N/A
- Earning Date
- FAMI 04-29-2025
- CINGW N/A
- Dividend Yield
- FAMI N/A
- CINGW N/A
- EPS Growth
- FAMI N/A
- CINGW N/A
- EPS
- FAMI N/A
- CINGW N/A
- Revenue
- FAMI $64,131,332.00
- CINGW N/A
- Revenue This Year
- FAMI N/A
- CINGW N/A
- Revenue Next Year
- FAMI N/A
- CINGW N/A
- P/E Ratio
- FAMI N/A
- CINGW N/A
- Revenue Growth
- FAMI N/A
- CINGW N/A
- 52 Week Low
- FAMI $1.43
- CINGW N/A
- 52 Week High
- FAMI $11.28
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- FAMI 38.42
- CINGW N/A
- Support Level
- FAMI $1.52
- CINGW N/A
- Resistance Level
- FAMI $1.70
- CINGW N/A
- Average True Range (ATR)
- FAMI 0.10
- CINGW 0.00
- MACD
- FAMI 0.04
- CINGW 0.00
- Stochastic Oscillator
- FAMI 69.23
- CINGW 0.00
About FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.